Wednesday, September 28, 2022
HomeBiotechnologyten23 well being completes superstructure of sterile manufacturing facility

ten23 well being completes superstructure of sterile manufacturing facility

Facebook
Twitter
Pinterest
WhatsApp

ten23 well being, a worldwide contract improvement and manufacturing group (CDMO) has accomplished the superstructure of its new sterile manufacturing facility.

The prevailing facility of ten23 well being’s swissfillon AG firm in Visp already affords sterile manufacturing of pre-filled syringes, vials, and cartridges for medical trial and business provides, in collaboration with ten23 well being’s improvement middle in Basel.

Ten23 acquired swissfillon in 2021. 

The brand new constructing, purpose-built for ten23 well being, contains two additional sterile manufacturing traces. Line 2 will produce giant business portions for market provide after regulatory approval of the drug. As a real scaled-up model of the prevailing filling line 1, the switch between the traces will probably be related to much less threat for biopharma prospects. 

The fill line will probably be based mostly on the newest Isolator expertise to extend the protection of the medicine for sufferers. It should concentrate on complicated merchandise, crammed into RTU containers together with syringes, cartridges and particular main packaging reminiscent of utilized in particular administration units for subcutaneous supply. Fill line 3 will broaden ten23 well being’s providing to additionally course of bulk containers (vials), each in liquid and lyophilized kind, with two large-scale freeze-dryers, every at 12.5 sq. meters of shelf-space for medical and business use. ten23 well being continues to rent further personnel to help the brand new manufacturing traces.  

A characteristic of the brand new facility is photovoltaic façade, protecting the entire constructing exteriors, and with the ability to present 45,000 kW per 12 months. ten23 well being’s amenities in Basel and Visp already function with 100% renewable power, according to ten23 well being’s dedication to serving to scale back greenhouse fuel emissions and saving.

Hanns-Christian Mahler, CEO of ten23 well being, stated: “The completion of the preliminary section of building is a significant milestone for ten23 well being, our prospects and their sufferers, and in direction of offering a major quantity of capability for business and medical sterile medicines for sufferers. Along with securing renewable power for the power, we’re investing in photovoltaics throughout the entire façade. We’re excited to proceed constructing ten23 well being into a number one sustainable contract improvement and manufacturing worldwide.”

Facebook
Twitter
Pinterest
WhatsApp
RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Recent Comments